Alkermes Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Substance Use Disorder Treatment (PHM035D)

Vivitrol (naltrexone for extended-release injectable suspension)

A once-monthly, injectable medication indicated for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification. Vivitrol uses polymer-based microsphere injectable extended-release technology to deliver and maintain therapeutic drug levels in the body with a single monthly intramuscular injection. Alkermes exclusively manufactures and commercializes Vivitrol in the U.S.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.